| Name | Title | Contact Details |
|---|---|---|
William Sweeney |
Chief Technology Officer and Chief Information Security Officer | Profile |
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
American Clinical Research Services is a company that provides clinical research services.
The patient adherence software platform for pharmaceutical brands. Use gamification, behavioral economics & loyalty marketing to drive patient adherence.
PRx is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CleanCare Healthcare Division is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.